Sodium Hyaluronate Ophthalmic Solution, 0.18% for Treatment of Dry Eye Syndrome

• Status: Completed
• Trial end date: 2012-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study was to determine if Sodium Hyaluronate, 0.18% is effective in treating the signs and symptoms of dry eye disease.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Alcon Research
• Treatments: Hyaluronic Acid; Ophthalmic Solutions; Pharmaceutical Solutions

Criteria

Inclusion Criteria:

• Documented history of dry eyes for at least 3 months.

• Ocular discomfort due to dry eyes.

• Presence of corneal and conjunctival staining.

• Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

• Women who are pregnant or lactating.

• Contact lens wear within 1 week before Screening and during the study.

• Ocular surgery (of any type, including laser surgery) or ocular trauma within the 4 months prior to Screening.

• Punctal plugs or punctal occlusion initiated within 3 months of screening

• Other protocol-defined exclusion criteria may apply.